Cambrex completes US$38 million capacity expansion in High Point, North Carolina

Evonik opens new facility for pharmaceutical lipids in Germany

New GMP facility for clinical and small-scale commercial pharmaceutical lipids

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases

This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies

CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production

The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe

AWS partners with Pfizer to accelerate drug development

It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies

Merck expands capacity for Antibody Drug Conjugate (ADC), therapies

Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges

AAV Production system enables scalable gene therapy workflows

New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments